SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) was down 1.2% during mid-day trading on Wednesday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares changed hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The company has a market capitalization of $6.64 billion, a PE ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The company’s fifty day moving average is $24.38 and its 200-day moving average is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Featured Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What Investors Need to Know to Beat the Market
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Compound Interest and Why It Matters When Investing
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
